Source: International Congress 2014 – COPD markers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Miravitlles, A. Huerta, F. García-Río, A. Fernández-Villar, B. Alcázar, C. Forné, M. Cuesta, M. Brosa (Barcelone, Madrid, Vigo, Loja (Granada), Spain). Impact of lung function impairment and exacerbation history on COPD patient-reported utility. Eur Respir J 2014; 44: Suppl. 58, 4735

Member's Comments

No comment yet.

Related content which might interest you: Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 The impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Collateral damage: Depressive symptoms in the spouses of COPD patients Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test Source: International Congress 2014 – Clinical presentations Year: 2014 Discordant symptom severity in COPD: The PHAROAH study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Quality of life (QL) depending on psychological disorders (PD) of patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Comorbidities Year: 2014 Predictive role of mMRC scale on quality of life in COPD patients Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2) Year: 2013 Development of the Manchester early morning symptoms index in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Clinical characteristics and health status of spontaneous sputum producers in COPD Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Longitudinal changes in COPD patients in primary care Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Assessment of quality of life of bronchiectasis patients associated with asthma and COPD. Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases Year: 2019 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 CAT-score is a predictor for mortality in COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Reduction in clinically important deterioration in COPD with aclidinium/formoterol Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Benefits of self-management education in COPD exacerbations Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Effect of roflumilast on quality of life in frequent and infrequent exacerbators Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013